Resmed Inc. buy Royal Bank of Canada
Start price
01.08.25
/
50%
€241.30
Target price
01.08.26
€262.86
Performance (%)
-1.99%
Price
05.09.25
€236.50
Summary
This prediction is currently active. With a performance of -1.99%, the BUY prediction for Resmed Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 01.08.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 0.853% | 0.853% |
| iShares Core DAX® | -1.150% | -0.950% |
| iShares Nasdaq 100 | 0.889% | 1.544% |
| iShares Nikkei 225® | 1.183% | 4.554% |
| iShares S&P 500 | 0.159% | 1.749% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Royal Bank Of Canada from $294.00 to $300.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat